Inspection Record

Central Admixture Pharmacy Services, Inc. — FDA 483 Findings

US FDAInspected 2018-08-22Published 2019-04-30 8 findingsQuality unit oversightAseptic processing and sterility assuranceDeviation, CAPA, and investigationEquipment and facilityDocumentation and records

Inspectors Gayle S LawsonThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

2Aseptic processing and sterility assurance

Each batch of drug product purporting to be sterile is not laboratory tested to determine conformance to such requirements.

3Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.

4Aseptic processing and sterility assurance

Separate or defined areas to prevent contamination or mix-ups are deficient regarding operations related to aseptic processing of drug products.

5Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

6Equipment and facility

Buildings used in the manufacture, processing, packing or holding of drug products are not maintained in a clean and sanitary condition and free of infestation by rodents, birds insects, and other vermin.

7Documentation and records

Procedures for the preparation ofmaster production and control records are not described in a written procedure.

8Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.

About this record

Extracted automatically from the document US FDA published on 2019-04-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Central Admixture Pharmacy Services, Inc. findings history — including this company's other documents US FDA documents, 2019 Go to Findings search